Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCinel, Güzin
dc.contributor.authorDoğru, Deniz
dc.contributor.authorÇakır, Erkan
dc.contributor.authorEyüboğlu, Tuğba Şişmanlar
dc.contributor.authorÇobanoğlu, Nazan
dc.contributor.authorPekcan, Sevgi
dc.contributor.authorYalçın, Ebru
dc.contributor.authorCan, Demet
dc.date.accessioned2021-03-09T08:38:18Z
dc.date.available2021-03-09T08:38:18Z
dc.date.issued2020en_US
dc.identifier.urihttps://doi.org/10.1183/13993003.congress-2020.2765
dc.identifier.urihttps://hdl.handle.net/20.500.12462/11165
dc.descriptionCan, Demet (Balikesir Author)en_US
dc.description.abstractAbstract Background: Cystic Fibrosis Registry of Turkey shows various CFTR mutations due to the geographical location and historical background of our country, and also high prevalence of consanguineous marriages. Method:All mutations detected in the Cystic Fibrosis Registry of Turkey 2017 (CFRT2017) data were screened in CFTR1 and CFTR2 databases. Mutations which were not found in both were identified and characteristics of these patients were compared with F508del homozygous patients. Results: Among 1170 registered patients, 978 were genotyped and 200 different mutations were shown in 1270 alleles.29 mutations were not reported in both databases; 58 mutations have been reported in CFTR1 but not in CFTR2. Demographic and phenotypic characteristics of the 112 patients with 87 different alleles those were not previously reported in the CFTR2 database (nonCFTR2 group) were compared with F508del homozygous 103 patients in CFRT2017. In the nonCFTR2 group, mean age was younger (5.81 vs 7.69; p:0.015), mean age at diagnosis was older (1.88 vs 1.08; p:0.041), sweat test was lower (75.12 vs 98.28; p<0.001), number of patients with chronic Pseudomonas aeruginosa colonisation was lower (17.9% vs 31.1%, p:0.041), number of patients with chronic Staphylococcus aureus colonisation was also lower (17.9% vs 34.0%; p:0.015) and CF related complications, eg. CF related diabetes was detected in fewer patients (1.8% vs 10.7%; p:0.002). Conclusion: We suggest that patients in the nonCFTR2 group have a mild clinical course, but in some patients, further investigations and functional studies are required for the exact diagnosis.en_US
dc.language.isoengen_US
dc.publisherEuropean Respiratory Soc Journals Ltden_US
dc.relation.isversionof10.1183/13993003.congress-2020.2765en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildrenen_US
dc.subjectCystic Fibrosisen_US
dc.subjectGeneticsen_US
dc.titleCFTR mutations unidentified in CFTR2 database and their phenotypic characteristics: Data from cystic fibrosis registry of Turkeyen_US
dc.typeotheren_US
dc.relation.journalEuropean Respiratory Journalsen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0002-1258-9348en_US
dc.identifier.volume56en_US
dc.identifier.issueSupplement: 64en_US
dc.identifier.startpage2765en_US
dc.identifier.endpage2765en_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster